Back
Leap Therapeutics Stock Price Chart

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
19
LPTX
Leap Therapeutics
Last Price:
$0.30
Seasonality Move:
-4.17%
7 Day Trial
ALL ACCESS PASS
$
7

Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LPTX is experiencing slight buying pressure.
Leap Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.36 | Sell |
20-day SMA: | 0.39 | Sell |
50-day SMA: | 0.6 | Sell |
200-day SMA: | 2.16 | Sell |
8-day EMA: | 0.35 | Sell |
20-day EMA: | 0.41 | Sell |
50-day EMA: | 0.81 | Sell |
200-day EMA: | 1.96 | Sell |
Leap Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 33.11 | Sell |
Chaikin Money Flow: | 550688 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.35 - 0.45) | Sell |
Bollinger Bands (100): | (0.54 - 3.06) | Sell |
Leap Therapeutics Technical Analysis
Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Leap Therapeutics Stock
Is Leap Therapeutics Stock a Buy?
-
Leap Therapeutics share price is 0.34 while LPTX 8-day simple moving average is 0.36, which is a Sell signal.
-
The stock price of LPTX is 0.34 while Leap Therapeutics 20-day SMA is 0.39, which makes it a Sell.
-
Leap Therapeutics 50-day simple moving average is 0.60 while LPTX share price is 0.34, making it a Sell technically.
-
LPTX stock price is 0.34 and Leap Therapeutics 200-day simple moving average is 2.16, creating a Sell signal.
LPTX Technical Analysis vs Fundamental Analysis
Sell
19
Leap Therapeutics (LPTX)
is a Sell
Is Leap Therapeutics a Buy or a Sell?
-
Leap Therapeutics stock is rated a SellThe current Leap Therapeutics [LPTX] share price is $0.34. The Score for LPTX is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
Leap Therapeutics Stock Info
Market Cap:
14M
Price in USD:
0.34
Share Volume:
2.6M
Leap Therapeutics 52-Week Range
52-Week High:
4.79
52-Week Low:
0.28
Sell
19
Leap Therapeutics (LPTX)
is a Sell
Leap Therapeutics Share Price Forecast
-
What is the Leap Therapeutics stock price today?The Leap Therapeutics stock price is 0.34 USD today.
-
Will LPTX stock go up or go down?Leap Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Leap Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Leap Therapeutics is overvalued.
Is Leap Therapeutics Stock a Buy?
-
Leap Therapeutics share price is 0.34 while LPTX 8-day exponential moving average is 0.35, which is a Sell signal.
-
The stock price of LPTX is 0.34 while Leap Therapeutics 20-day EMA is 0.41, which makes it a Sell.
-
Leap Therapeutics 50-day exponential moving average is 0.81 while LPTX share price is 0.34, making it a Sell technically.
-
LPTX stock price is 0.34 and Leap Therapeutics 200-day simple moving average is 1.96, creating a Sell signal.
Fundamental Analysis of Leap Therapeutics
Is Leap Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.56 per share, and an increase next year of $0.39 per share.
Technical Analysis of Leap Therapeutics
Should I short Leap Therapeutics stock?
-
LPTX Moving Average Covergence Divergence (MACD) indicator is -0.1, suggesting Leap Therapeutics is a Sell
-
Leap Therapeutics Relative Strength Index (RSI) is 33.11, which suggest Leap Therapeutics is oversold
-
The Bollinger Bands (25) for Leap Therapeutics is (0.35 - 0.45), which suggest Leap Therapeutics is a Sell
-
The Bollinger Bands (100) for Leap Therapeutics is (0.54 - 3.06), which suggest Leap Therapeutics is a Sell
* Leap Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.